`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`C.A. No. 20-1098-GBW
`
`W. R. GRACE & CO.-CONN.,
`
`Plaintiff,
`
`V.
`
`ELYSIUM HEAL TH, INC.,
`
`Defendant.
`
`VERDICT FORM
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 2 of 12 PageID #: 18697
`
`INSTRUCTIONS
`
`When answering the following questions and completing this Verdict Form, please
`
`follow the directions provided throughout the form. Your answer to each question must be
`
`unanimous. Some of the questions contain legal terms that are defined and explained in detail in
`
`the Jury Instructions. Please refer to the Jury Instructions for guidance on the law applicable to
`
`each question.
`
`• You should answer all of questions 1 to 8.
`
`• Whether you answer questions 9 to 11 , which concern the issues of damages and
`
`willfulness, will depend on the answers you give to questions 1 to 8 as indicated
`
`by the additional instructions provided with each set of questions.
`
`2
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 3 of 12 PageID #: 18698
`
`FINDINGS ON INFRINGEMENT
`
`Directions: The questions regarding infringement should be answered regardless of your findings
`with respect to the validity or invalidity of the patents.
`
`1. Direct Infringement of the Asserted Claims
`
`Has Grace proven by a preponderance of the evidence that Elysium has directly infringed any of the
`asserted claims? Check YES or NO for each claim.
`Checking "yes " below indicates a finding for Grace
`Checking "no " below indicates afindingfor Elysium
`
`YES (Elysium NO (Elysium
`infringes)
`does not infringe)
`
`YES (Elysium NO (Elysium
`infringes)
`does not infringe)
`
`Claim 1
`
`Claim 2
`
`Claim 21
`
`'058 Patent
`
`✓
`✓-
`✓
`
`Claim 1
`
`Claim 6
`
`Claim 15
`
`' 872 Patent
`✓
`✓-
`✓
`
`3
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 4 of 12 PageID #: 18699
`
`2. Induced Infringement of an Asserted Claim
`
`Has Grace proven by a preponderance of the evidence that Elysium has induced infringement of the
`following asserted claim?
`Checking "yes " below indicates a finding for Grace
`Checking "no " below indicates a finding for Elysium
`
`YES (Elysium
`infringes)
`
`NO (Elysium
`does not infringe)
`
`Claim 21
`
`' 058 Patent
`✓
`
`4
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 5 of 12 PageID #: 18700
`
`3. Contributory Infringement of an Asserted Claims
`
`Has Grace proven by a preponderance of the evidence that Elysium has contributed to the infringement of
`the following asserted claim?
`Checking "yes" below indicates afindingfor Grace
`Checking "no " below indicates a finding for Elysium
`
`YES (Elysium
`infringes)
`
`NO (Elysium
`does not infringe)
`
`Claim 21
`
`'05 8 Patent
`✓
`
`5
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 6 of 12 PageID #: 18701
`
`FINDINGS ON INVALIDITY
`
`Direction for Question 4: The questions regarding invalidity should be answered regardless of
`your findings with respect to the infringement or noninfringement of the patents.
`
`4. Anticipation of the Asserted Claims (35 U.S.C. §102(a)- On-Sale)
`Has Elysium proven by clear and convincing evidence that any of the asserted claims are invalid because
`the invention was offered for sale or sold prior to the applicable critical date? Check YES or NO for each
`claim.
`
`Checking "yes" below indicates a finding for Elysium
`Checking "no " below indicates a finding for Grace
`
`YES ( claim is
`invalid for being
`on-sale)
`
`NO (claim is not
`invalid for being
`on-sale)
`
`'058 Patent (critical date July 24, 2013)
`
`Claim 1
`
`Claim 2
`
`Claim 21
`
`✓
`,/
`1/
`
`6
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 7 of 12 PageID #: 18702
`
`5. Anticipation of the Asserted Claims (35 U.S.C. §102(a)-Prior Art)
`
`Question 5: Has Elysium proven by clear and convincing evidence that any of the asserted claims of the
`' 058 patent are invalid because the invention was anticipated by International Publication No. WO
`2015/186068 Al ("the GSK reference")? Check YES or NO for each claim.
`Checking "yes" below indicates ajindingfor Elysium
`Checking "no " below indicates a finding for Grace
`
`YES (claim is
`invalid for being
`anticipated)
`
`NO (claim is not
`invalid for being
`anticipated)
`
`'058 Patent (critical date July 24, 2013)
`
`Claim 1
`
`Claim 2
`
`Claim 21
`
`v
`✓
`✓
`
`7
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 8 of 12 PageID #: 18703
`
`6. Written Description Requirement for the Asserted Claims (35 U.S.C. §
`112(a))
`
`Has Elysium proven by clear and convincing evidence that any of the asserted claims are invalid because
`the patent specification does not contain an adequate written description of the invention? Check YES or
`NO for each claim.
`Checking "yes" below indicates afindingfor Elysium
`Checking "no " below indicates a finding for Grace
`
`YES (claim is
`invalid for lack
`of written
`description)
`
`NO (claim is not
`invalid for lack of
`written
`description)
`
`YES (claim is
`invalid for lack
`of written
`description)
`
`NO (claim is not
`invalid for lack of
`written
`description)
`
`' 058 Patent
`
`' 872 Patent
`
`Claim 1
`
`Claim 2
`
`Claim 21
`
`,/
`✓
`✓
`
`Claim 1
`
`Claim 6
`
`Claim 15
`
`✓
`✓
`✓
`
`8
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 9 of 12 PageID #: 18704
`
`7. Enablement of the Asserted Claims (35 U.S.C. §112(a))
`
`Has Elysium proven by clear and convincing evidence that any of the asserted claims are invalid because
`the patent specification does not enable persons of ordinary skill in the field to make or use the
`invention? Check YES or NO for each claim.
`Checking "yes" below indicates afindingfor Elysium
`Checking "no " below indicates afindingfor Grace
`
`YES ( claim is
`invalid for lack
`of enablement)
`
`NO (claim is not
`invalid for lack of
`enablement)
`
`YES ( claim is
`invalid for lack
`of enablement)
`
`NO (claim is not
`invalid for lack of
`enablement)
`
`' 058 Patent
`
`' 872 Patent
`
`Claim I
`
`Claim 2
`
`Claim 21
`
`✓
`✓
`✓
`
`Claim I
`
`Claim 6
`
`Claim 15
`
`✓
`✓
`✓
`
`9
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 10 of 12 PageID #: 18705
`
`8. Indefiniteness of the Certain Asserted Claims (35 U.S.C. §112(b))
`
`Has Elysium proven by clear and convincing evidence that any of the asserted claims are invalid for
`indefiniteness? Check YES or NO for each claim.
`Checking ''yes " below indicates afindingfor Elysium
`Checking "no " below indicates a finding for Grace
`
`YES (claim is
`invalid for lack
`of enablement)
`
`NO (claim is not
`invalid for lack of
`enablement)
`
`YES ( claim is
`invalid for lack
`of enablement)
`
`NO (claim is not
`invalid for lack of
`enablement)
`
`'058 Patent
`
`' 872 Patent
`
`l/
`✓/
`✓
`
`Claim 1
`
`Claim 6
`
`Claim 15
`
`,/
`✓
`✓
`
`Claim 1
`
`Claim 2
`
`Claim 21
`
`10
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 11 of 12 PageID #: 18706
`
`FINDINGS ON DAMAGES {IF APPLICABLE)
`
`If you answered "yes" for any claims in questions 1-3 and did not answer "yes" for those claims
`in questions 4-8, answer the following questions.
`
`Question 9: What is (a) the reasonable royalty rate (in percent), (b) the royalty base (in dollars),
`and (c) the total amount of damages (in dollars) that results from applying the reasonable royalty
`rate to the royalty base, that Grace has proven by a preponderance of the evidence would
`compensate it for Elysium's infringement for the time period from August 21, 2020 to March 31,
`2023?
`
`a) Royalty Rate: !1£%
`b) Royalty Base: $ ~ll ,~~~ ~~o
`c) Total Damages:$ d 14tfb,9'q5
`
`Question 10: What is (a) the reasonable royalty rate (in percent), (b) the royalty base (in dollars),
`and ( c) the total amount of damages (in dollars) that results from applying the reasonable royalty
`rate to the royalty base, that Grace has proven by a preponderance of the evidence would
`compensate it for Elysium' s infringement for the time period from July 2017 to January 29,
`2019?
`
`a) Royalty Rate: 3-~5%
`b) Royalty Base: $ ~]l 5% t'cto(
`c) Total Damages:$ I I >hd ,1st{
`
`11
`
`
`
`Case 1:20-cv-01098-GBW-JLH Document 313 Filed 08/25/23 Page 12 of 12 PageID #: 18707
`
`FINDINGS ON WILLFUL INFRINGEMENT QF APPLICABLE)
`
`Direction for Question ll(a): Only answer Question 1 l(a) if you answered "yes" for any claims
`of the '058 patent in questions 1-3 and did not answer ''yes" for those claims in questions 4-8.
`
`Otherwise, skip Questions 1 l(a) and proceed to the Directions for Question 1 l(b).
`
`Question ll(a): Has Grace proven by a preponderance of the evidence that Elysium willfully infringed
`any valid asserted claim of the '058 patent?
`
`Checking "yes" below indicates a.finding for Grace
`Checking "no" below indicates a.finding for Elysium
`Yes ✓ No
`
`Direction for Question ll(b): Only answer Question 1 l(b) if you answered ''yes" for any
`claims of the '872 patent in question 1 and did not answer ''yes" for those claims in questions 6-
`8.
`
`Question ll(b): Has Grace proven by a preponderance of the evidence that Elysium willfully infringed
`any valid asserted claim of the ' 872 patent?
`
`Checking "yes" below indicates a.finding for Grace
`Checkin~ 'no " below indicates a finding for Elysium
`
`Yes
`
`,./ No
`
`*
`
`*
`
`*
`
`You have now reached the end of the verdict form and should review it to ensure that it
`accurately reflects your unanimous decisions. The Foreperson should then sign and date the
`verdict form in the spaces below and notify the Courtroom Deputy that you have reached a
`verdict. The Foreperson should retain possession of the verdict form and bring it when the jury
`is brought back into the courtroom.
`
`Date: August 1 :) , 2023
`
`12
`
`